Wells Fargo & Company V Tv Therapeutics Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.42 - $0.75 $92 - $165	220 Added 17.9%	1,449 $0
Q2 2023 Aug 15, 2023	BUY	$0.72 - $0.95 $6 - $8	9 Added 0.74%	1,229 $0
Q1 2023 May 12, 2023	BUY	$0.72 - $1.01 $2 - $4	4 Added 0.33%	1,220 $0
Q4 2022 Feb 13, 2023	SELL	$0.66 - $1.02 $656 - $1,014	-995 Reduced 45.0%	1,216 $0
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.37 $655 - $1,382	1,009 Added 83.94%	2,211 $2,000

Q2 2022 Aug 12, 2022	BUY	$0.39 - $0.84 $6 - $14	17 Added 1.43%	1,202 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.69 $911 - $1,620	-959 Reduced 44.73%	1,185 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.53 - $2.22 $29 - $42	19 Added 0.89%	2,144 $3,000
Q2 2021 Aug 16, 2021	SELL	$2.27 - $3.44 $19,394 - $29,391	-8,544 Reduced 80.08%	2,125 $5,000
Q1 2021 May 13, 2021	SELL	$1.97 - $2.89 $22,489 - $32,992	-11,416 Reduced 51.69%	10,669 $30,000
Q4 2020 Feb 09, 2021	SELL	$1.49 - $3.1 $101,741 - $211,677	-68,283 Reduced 75.56%	22,085 $41,000
Q3 2020 Nov 05, 2020	BUY	$1.7 - $2.98 $144,345 - $253,028	84,909 Added 1555.39%	90,368 $159,000
Q2 2020 Aug 13, 2020	BUY	$1.74 - $3.19 $8,632 - $15,825	4,961 Added 996.18%	5,459 $12,000
Q1 2020 May 14, 2020	BUY	$1.63 - $3.75 $811 - $1,867	498 New	498 $1,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.44B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.